ABOUT CONFERENCE
We are delighted to invite you 4th Inhalation & Respiratory Drug Delivery Online Conference that will be held Online on 25-26th of February 2021 at 15:00 CET on BigMarker.
4th Inhalation & Respiratory Drug Delivery Online Conference will give you a unique opportunity to discuss last trends and innovations in inhalation technologies, the new challenges and approaches of the inhaler models on the market. The agenda also features digital future of effective respiratory devices, key studies on the latest trends in inhalation devices and personalized treatments with large and small molecules for different respiratory diseases.
Presentations will also be focused on the topics, such as: pMDI, APIs/Drug and the future potential for effective OINDPs treatment lung infection. The event is modeled for the senior manager representatives, experts and main decision makers who are interested to be acquainted with the latest approaches and inventions of the respiratory drug products delivery field.
- Micronization: of The API/Drug
- Environmental Friendliness of MDI & DPI Inhaler
- Regulation Status Of Drug Delivery Devices After Brexit
- Effective OINDPs Treatment Lung Infection
- Design & Functionality in DPI/MDI
- Last Trends & Innovations
- Smart Inhalers in RDD Market
Who should attend
CEOs / VPs / Drug Developers / Academics and Researchers /
CROs / Scientists and Medical Doctors of:
- Respiratory Drug Development
- Generics & Respiratory
- Inhalation Drug Delivery Technologies
- Device Development and Engineering
- Respiratory Pharmacology
- Medical Devices & Injectors
- Inhalation Device Development
- Inhaled Formulation Science
- Inhalation Product Development
- Respiratory Regulations
- Generics & Respiratory
- Inhalation Process Development
- Respiratory Medicine
- Inhalation Drug Delivery
- E-Health
- Inhaled Dosage Forms
- Outsourcing
- Process Development
- Respiratory Pharmacology
- Device Engineering
- Drug Delivery Innovation
- Inhalation Devices
- Metered Dose Inhaler Development
- Medical Marketing
- Respiratory R&D
- Particle Characterisation
- Business Development
- New Delivery Technologies
- Connective Health
- Respiratory Regulations
- Pulmonary Disease
- Inhalation
- Scientific Research
ONLINE CONFERENCE INCLUDES
- 7+ different topics
- panel discussion
- networking with business professionals and industry experts
- additional materials
15:00 – 15:10 CET
Welcome and opening remarks from the moderator
15:10 – 15:35 CET
Developing Advanced Characterization Tools to Facilitate Alternative Bioequivalence Strategies for ONIDPs + Q&A
15:35 – 15:55 CET
New Opportunities In Patient Treatment With Connected Nebulizer Platforms & Monitoring Devices In Holistic Therapy Eco Systems + Q&A
15:55 – 16:00 CET
BREAK
16:00 – 16:25 CET
Understanding Inhalation Pre-clinical Development + Q&A
16:25 – 16:50 CET
Quality by Design for API Development as Success for Respiratory + Q&A
16:55 – 17:20 CET
The Next Generation Drug Carrier for Inhaled Formulations + Q&A
17:20 – 17:45 CET
Evolutions of single-dose reusable Dry Powder Inhalers Steps in direction of patient centricity and environmental sustainability.
17:450 – 17:55 CET
CLOSING SESSION REMARKS
15:00 – 15:10 CET
Welcome and opening remarks from the moderator
15:10 – 15:35 CET
Phase Appropriate Combination Product Development & Life Cycle Management + Q&A
15:35 – 15:55 CET
Strategies to Accelerate Robust Dry PowderInhaler Development: Utilizing a Multivariate Approach to Understand the Role of Excipient Variation + Q&A
15:55 – 16:00 CET
BREAK
16:00 – 16:25 CET
Simplifying the Manufacturing Process for HFC 152a and Other Propellants + Q&A
16:25 – 16:50 CET
Novel Approaches for Systemic Drug Delivery via the Lungs + Q&A
16:55 – 17:20 CET
Trends and Innovations in the Field of Micronization of Inhalation Products and HPAPIs + Q&A
17:20 – 17:30 CET
CLOSING SESSION REMARKS
